BioPharma Credit PLC (BPCR.L)

USD 0.89

(0.91%)

EBITDA Summary of BioPharma Credit PLC

  • BioPharma Credit PLC's latest annual EBITDA in 2023 was - USD , down -40.51% from previous year.
  • BioPharma Credit PLC's latest quarterly EBITDA in 2024 Q2 was 71.83 Million USD , up 80616.85% from previous quarter.
  • BioPharma Credit PLC reported an annual EBITDA of - USD in 2022, up 114.59% from previous year.
  • BioPharma Credit PLC reported an annual EBITDA of - USD in 2021, down -4.69% from previous year.
  • BioPharma Credit PLC reported a quarterly EBITDA of 71.83 Million USD for 2024 Q2, up 80616.85% from previous quarter.
  • BioPharma Credit PLC reported a quarterly EBITDA of -3500.00 USD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of BioPharma Credit PLC (2023 - 2017)

Historical Annual EBITDA of BioPharma Credit PLC (2023 - 2017)

Year EBITDA EBITDA Growth
2023 - USD -40.51%
2022 - USD 114.59%
2021 - USD -4.69%
2020 - USD -27.13%
2019 - USD 74.38%
2018 - USD 174027.49%
2017 - USD 0.0%

Peer EBITDA Comparison of BioPharma Credit PLC